# Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants

> **NCT02685969** · — · RECRUITING · sponsor: **Barcelonabeta Brain Research Center, Pasqual Maragall Foundation** · enrollment: 570 (estimated)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **PROCEDURE:** 18F-Flutemetamol & 18F-FDG

## Key facts

- **NCT ID:** NCT02685969
- **Lead sponsor:** Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-03-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 570 (ESTIMATED)
- **Last updated:** 2025-05-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02685969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02685969, "Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02685969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*